drugset / Trial / NCT02535000
Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
Duloxetine as an analgesic agent in patients undergoing elective spine surgery: evaluation with fentanyl demand controlled by the patient. The primary objective is to evaluate the efficacy of duloxetine in fentanyl consumption during the postoperative period of patients undergoing elective spine surgery by intervertebral disc degeneration . Secondary endpoints were pain scores and the presence or absence of adverse effects such as headache, nausea, vomiting, itching, dizziness and drowsiness.
Timeline
- Start
- 2014-01-01
- Primary completion
- 2015-10-20
- Completion
- 2015-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duloxetine | Small molecule | 60 mg | Oral |